InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Lloyd-Smith Malcolm, Directeur Réglementaire. Director active across 1 company, notably Neurocrine Biosciences INC. Cumulatively, 5 filings have been logged. Split: 0 buy · 4 sells. Total volume traded: €1.6m. Activity tracked since 27 July 2021. The latest transaction was disclosed on 6 February 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lloyd-Smith Malcolm
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
801 shares@ US$105.81532.1% of flowCommon StockSEC:0001209191-23-007914:0
1,666 shares@ US$110.01834.5% of flowCommon StockSEC:0001209191-23-006280:0
21,533 shares@ US$35.9919.9% of flowCommon StockSEC:0001209191-22-046070:0
865 shares@ US$80.78142.6% of flowCommon StockSEC:0001209191-22-008214:0
16,709 shares@ US$93.801955.6% of flowCommon StockSEC:0001209191-21-048560:0
5 of 5 declarations
About Lloyd-Smith Malcolm
Lloyd-Smith Malcolm is the Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC. He is responsible for regulatory compliance and risk management. His role is essential in ensuring that the company adheres to all applicable regulations in the biotechnology sector.
